MMJ International Holdings has applied to the U.S. Patent and Trademark Office (USPTO) for new pharmaceutical compounds and methods to treat and prevent symptoms associated with multiple sclerosis (MS) and other diseases responsive to cannabinoids . The patent covers MMJ BioScience’s … Read More
The post MMJ Files US Patent for Multiple Sclerosis Cannabinoid Treatment appeared first on Dagga Magazine.